BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Okamoto E, Osaki M, Kase S, Adachi H, Kaibara N, Ito H. Thymidine phosphorylase expression causes both the increase of intratumoral microvessels and decrease of apoptosis in human esophageal carcinomas. Pathol Int. 2001;51:158-164. [PMID: 11328530 DOI: 10.1046/j.1440-1827.2001.01184.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Lin Z, Zhang X, Luo Y, Chen Y, Yuan Y. The value of hemoglobin-to-red blood cell distribution width ratio (Hb/RDW), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) for the diagnosis of nasopharyngeal cancer. Medicine (Baltimore) 2021;100:e26537. [PMID: 34260530 DOI: 10.1097/MD.0000000000026537] [Reference Citation Analysis]
2 Ye S, Bai L. Comparison and validation of the value of preoperative inflammation marker-based prognostic scores in resectable pancreatic ductal adenocarcinoma. Cancer Manag Res 2018;10:3405-17. [PMID: 30237742 DOI: 10.2147/CMAR.S173444] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
3 Li W, Yue H. Thymidine phosphorylase: A potential new target for treating cardiovascular disease. Trends Cardiovasc Med 2018;28:157-71. [PMID: 29108898 DOI: 10.1016/j.tcm.2017.10.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
4 Su L, Zhang M, Zhang W, Cai C, Hong J. Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis. Medicine (Baltimore) 2017;96:e6364. [PMID: 28296774 DOI: 10.1097/MD.0000000000006364] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
5 Iqbal H, Pan Q. Capecitabine for treating head and neck cancer. Expert Opin Investig Drugs 2016;25:851-9. [PMID: 27144283 DOI: 10.1080/13543784.2016.1181747] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
6 Chen YP, Zhao BC, Chen C, Shen LJ, Gao J, Mai ZY, Chen MK, Chen G, Yan F, Liu S, Xia YF. Pretreatment platelet count improves the prognostic performance of the TNM staging system and aids in planning therapeutic regimens for nasopharyngeal carcinoma: a single-institutional study of 2,626 patients. Chin J Cancer 2015;34:137-46. [PMID: 25962816 DOI: 10.1186/s40880-015-0006-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
7 Chen YP, Chen C, Mai ZY, Gao J, Shen LJ, Zhao BC, Chen MK, Chen G, Yan F, Huang TY, Xia YF. Pretreatment platelet count as a predictor for survival and distant metastasis in nasopharyngeal carcinoma patients. Oncol Lett 2015;9:1458-66. [PMID: 25663931 DOI: 10.3892/ol.2015.2872] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
8 Nie X, Bhat R, Al-Saleem ED, Vonderheid EC, Hou JS. Expression of thymidine phosphorylase in lymph nodes involved with mycosis fungoides and sézary syndrome. Adv Hematol 2011;2011:875135. [PMID: 22162690 DOI: 10.1155/2011/875135] [Reference Citation Analysis]
9 Won Y, Park Y, Ahn M, Do I, Ko Y, Park K. A phase II study of combination chemotherapy with capecitabine and cisplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck. Annals of Oncology 2011;22:417-23. [DOI: 10.1093/annonc/mdq355] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
10 Bronckaers A, Gago F, Balzarini J, Liekens S. The dual role of thymidine phosphorylase in cancer development and chemotherapy. Med Res Rev. 2009;29:903-953. [PMID: 19434693 DOI: 10.1002/med.20159] [Cited by in Crossref: 128] [Cited by in F6Publishing: 120] [Article Influence: 10.7] [Reference Citation Analysis]
11 Yu XQ. Preoperative administration of xeloda on the angiogenesis and expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in colorectal cancer. Shijie Huaren Xiaohua Zazhi 2007; 15(1): 95-98 [DOI: 10.11569/wcjd.v15.i1.95] [Reference Citation Analysis]
12 Kase S, Saito W, Yoshida K, Namba K, Osaki M, Ohgami K, Shiratori K, Kitaichi N, Adachi H, Ito H, Ohno S. Expression of thymidine phosphorylase in choroidal malignant melanoma associated with neovascular glaucoma. Pathol Int 2005;55:569-73. [PMID: 16143032 DOI: 10.1111/j.1440-1827.2005.01870.x] [Reference Citation Analysis]
13 Hitt R, Jimeno A, Rodríguez-Pinilla M, Rodríguez-Peralto JL, Millán JM, López-Martín A, Brandariz A, Peña C, Cortés-Funes H. Phase II trial of cisplatin and capecitabine in patients with squamous cell carcinoma of the head and neck, and correlative study of angiogenic factors. Br J Cancer 2004;91:2005-11. [PMID: 15597103 DOI: 10.1038/sj.bjc.6602275] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
14 Liekens S, Hernández AI, Ribatti D, De Clercq E, Camarasa MJ, Pérez-Pérez MJ, Balzarini J. The nucleoside derivative 5'-O-trityl-inosine (KIN59) suppresses thymidine phosphorylase-triggered angiogenesis via a noncompetitive mechanism of action. J Biol Chem 2004;279:29598-605. [PMID: 15123637 DOI: 10.1074/jbc.M402602200] [Cited by in Crossref: 37] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
15 Noguchi T, Moriyama H, Wada S, Takeno S, Kimura Y, Uchida Y, Gabbert HE. High level concentration of pyrimidine nucleoside phosphorylase in esophageal squamous cell carcinoma but no correlation with clinicopathological parameters. Diseases of the Esophagus 2003;16:307-11. [DOI: 10.1111/j.1442-2050.2003.00352.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Poon RT, Fan ST, Wong J. Clinical significance of angiogenesis in gastrointestinal cancers: a target for novel prognostic and therapeutic approaches. Ann Surg. 2003;238:9-28. [PMID: 12832961 DOI: 10.1097/00000658-200307000-00003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
17 Poon RT, Fan ST, Wong J. Clinical significance of angiogenesis in gastrointestinal cancers: a target for novel prognostic and therapeutic approaches. Ann Surg. 2003;238:9-28. [PMID: 12832961 DOI: 10.1097/01.sla.0000075047.47175.35] [Cited by in Crossref: 28] [Cited by in F6Publishing: 39] [Article Influence: 1.5] [Reference Citation Analysis]
18 Yu XQ, Deng CS, Zhu YQ, Cheng FZ. Expression and significance of thymidine phosphorylase/platelet-derived endothelial cell growth factor in human colorectal cancer tissue. Shijie Huaren Xiaohua Zazhi 2003; 11(8): 1197-1199 [DOI: 10.11569/wcjd.v11.i8.1197] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Liekens S, Bilsen F, De Clercq E, Priego EM, Camarasa MJ, Pérez-Pérez MJ, Balzarini J. Anti-angiogenic activity of a novel multi-substrate analogue inhibitor of thymidine phosphorylase. FEBS Lett 2002;510:83-8. [PMID: 11755536 DOI: 10.1016/s0014-5793(01)03233-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]